SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

GRAZI, Gian Luca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.031
AS - Asia 4.799
EU - Europa 1.387
SA - Sud America 1.331
AF - Africa 154
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 3
Totale 12.714
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.844
SG - Singapore 2.132
BR - Brasile 1.014
CN - Cina 720
HK - Hong Kong 585
VN - Vietnam 533
IT - Italia 237
FI - Finlandia 227
RU - Federazione Russa 203
ID - Indonesia 179
JP - Giappone 175
FR - Francia 170
DE - Germania 150
GB - Regno Unito 132
IN - India 112
AR - Argentina 102
MX - Messico 97
BD - Bangladesh 79
UA - Ucraina 58
CO - Colombia 56
TR - Turchia 51
ZA - Sudafrica 51
EC - Ecuador 50
NL - Olanda 49
AT - Austria 48
CA - Canada 45
IQ - Iraq 40
CL - Cile 30
PK - Pakistan 28
PY - Paraguay 27
VE - Venezuela 27
SE - Svezia 25
ES - Italia 23
MA - Marocco 23
SA - Arabia Saudita 23
UZ - Uzbekistan 20
KE - Kenya 18
MY - Malesia 16
DZ - Algeria 15
PH - Filippine 14
TN - Tunisia 13
JM - Giamaica 12
AZ - Azerbaigian 10
PE - Perù 10
DO - Repubblica Dominicana 9
JO - Giordania 9
AE - Emirati Arabi Uniti 8
BO - Bolivia 8
CR - Costa Rica 8
EG - Egitto 8
LT - Lituania 8
NP - Nepal 8
PL - Polonia 8
IE - Irlanda 7
UY - Uruguay 7
AL - Albania 6
AU - Australia 6
BH - Bahrain 6
IL - Israele 6
TW - Taiwan 6
BY - Bielorussia 5
ET - Etiopia 5
KR - Corea 5
KZ - Kazakistan 5
SN - Senegal 5
BE - Belgio 4
OM - Oman 4
CH - Svizzera 3
DK - Danimarca 3
EE - Estonia 3
HN - Honduras 3
LB - Libano 3
MO - Macao, regione amministrativa speciale della Cina 3
NG - Nigeria 3
NZ - Nuova Zelanda 3
TH - Thailandia 3
AM - Armenia 2
AO - Angola 2
BG - Bulgaria 2
CZ - Repubblica Ceca 2
EU - Europa 2
HU - Ungheria 2
IR - Iran 2
KW - Kuwait 2
LV - Lettonia 2
PA - Panama 2
PS - Palestinian Territory 2
RS - Serbia 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
UG - Uganda 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AI - Anguilla 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BJ - Benin 1
BW - Botswana 1
CD - Congo 1
CU - Cuba 1
Totale 12.691
Salva come PNG Salva come JPEG
Città #
Singapore 1.118
Santa Clara 741
Ashburn 733
San Jose 708
Hong Kong 582
Fairfield 273
Beijing 247
Council Bluffs 243
Helsinki 219
Ho Chi Minh City 187
Tokyo 171
Chandler 165
Lauterbourg 148
Jakarta 133
Hanoi 121
Woodbridge 103
Houston 99
São Paulo 81
Seattle 74
Wilmington 73
Princeton 72
Mexico City 68
New York 59
Cambridge 58
Moscow 56
Dallas 53
Chicago 52
Orem 48
Los Angeles 46
San Diego 44
Nuremberg 42
Ann Arbor 40
London 39
Shanghai 39
Rio de Janeiro 32
Haiphong 23
Salt Lake City 23
Vienna 23
Baghdad 22
Rome 22
Belo Horizonte 21
Jacksonville 21
Chennai 20
Da Nang 20
Quito 20
Curitiba 19
Guangzhou 18
Medellín 18
Porto Alegre 18
Tashkent 18
Frankfurt am Main 17
Milan 17
Biên Hòa 16
Brasília 16
Falkenstein 16
Falls Church 16
Portsmouth 16
Montreal 15
Ferrara 14
Nairobi 14
Caracas 13
Dhaka 13
Guayaquil 13
Johannesburg 13
Manchester 13
Bologna 12
Brooklyn 12
Fortaleza 12
Guarulhos 12
Istanbul 12
Buenos Aires 11
Mumbai 11
Amsterdam 10
Asunción 10
Campinas 10
Hangzhou 10
Salvador 10
Santiago 10
Toronto 10
Amman 9
Ankara 9
Baku 9
Hải Dương 9
Juiz de Fora 9
New Delhi 9
St Petersburg 9
Tampa 9
Can Tho 8
Casablanca 8
Osasco 8
Ribeirão Preto 8
Xian 8
Cape Town 7
Carapicuíba 7
Duque de Caxias 7
Düsseldorf 7
Hounslow 7
Kilburn 7
Lima 7
Manaus 7
Totale 7.815
Salva come PNG Salva come JPEG
Nome #
MiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cells 204
MicroRNA-221 targets Bmf in hepatocellular carcinoma and correlates with tumor multifocality 169
MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells 169
The Immune Landscape of Cancer 136
Tumor Regression Grade After Neoadjuvant Chemoradiation and Surgery for Low Rectal Cancer Evaluated by Multiple Correspondence Analysis: Ten Years as Minimum Follow-up 134
A case report of giant hepatic hemangioma spontaneous regression in adult, non-cirrhotic patient and literature review 134
A Pan-Cancer Analysis of Enhancer Expression in Nearly 9000 Patient Samples 133
Early onset aggressive hereditary amyloidosis: report of an Italian family with TTR Arg47 mutation. 129
An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics 127
Adjuvant, adoptive immunotherapy with tumor infiltrating lymphocytes plus interleukin-2 after radical hepatic resection for colorectal liver metastases: 5-year analysis 125
Oncogenic Signaling Pathways in The Cancer Genome Atlas 125
A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast Cancers 121
The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma 106
ALPPS for primary and secondary liver tumors 104
A Pan-Cancer Analysis Reveals High-Frequency Genetic Alterations in Mediators of Signaling by the TGF-β Superfamily 103
Perspective on Oncogenic Processes at the End of the Beginning of Cancer Genomics 101
Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer 100
Comprehensive Characterization of Cancer Driver Genes and Mutations 100
Criteria for diagnosing benign portal vein thrombosis in the assessment of patients with cirrhosis and hepatocellular carcinoma for liver transplantation 100
Scalable Open Science Approach for Mutation Calling of Tumor Exomes Using Multiple Genomic Pipelines 96
Anti-HBs re-seroconversion after liver transplantation in a patient with past HBV infection receiving a HBsAg positive graft 96
Cholangiocarcinoma landscape in Europe: diagnostic, prognostic and therapeutic insights from the ENSCCA Registry 96
Performance of comprehensive complication index and clavien‐dindo complication scoring system in liver surgery for hepatocellular carcinoma 94
Comprehensive Molecular Characterization of the Hippo Signaling Pathway in Cancer 93
Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas 93
Pathogenic Germline Variants in 10,389 Adult Cancers 92
Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients 91
Hepatocellular carcinoma surgical and oncological trends in a national multicentric population: the HERCOLES experience 89
A Novel Nomogram to Predict the Prognosis of Patients Undergoing Liver Resection for Neuroendocrine Liver Metastasis: an Analysis of the Italian Neuroendocrine Liver Metastasis Database 89
DCLK1, a putative novel stem cell marker in human cholangiocarcinoma 89
Metformin exerts anti-cancerogenic effects and reverses epithelial-to-mesenchymal transition trait in primary human intrahepatic cholangiocarcinoma cells 89
A new priority policy for patients with hepatocellular carcinoma awaiting liver transplantation within the model for end-stage liver disease system 88
Renewed considerations on the utility (or the futility) of hepatic resections for breast cancer liver metastases 88
The actin modulator hMENA regulates GAS6-AXL axis and pro-tumor cancer/stromal cell cooperation 86
Genomic and Functional Approaches to Understanding Cancer Aneuploidy 85
The Impact of Hospital Volume on Failure to Rescue after Liver Resection for Hepatocellular Carcinoma: Analysis from the HE.RC.O.LE.S. Italian Registry 85
Harm and benefits of primary liver resection and salvage transplantation for hepatocellular carcinoma 85
Partial necrosis on hepatocellular carcinoma nodules facilitates tumor recurrence after liver transplantation 84
Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation 83
Primary leiomyoma of the liver in an immunocompetent patient 82
Effect of ischemic preconditioning in whole liver transplantation from deceased donors. A pilot study 82
Genetically driven CD39 expression shapes human tumor-infiltrating CD8+ T-cell functions 81
lncRNA Epigenetic Landscape Analysis Identifies EPIC1 as an Oncogenic lncRNA that Interacts with MYC and Promotes Cell-Cycle Progression in Cancer 81
Wnt3a/b-Catenin signaling conditions differentiation of partially exhausted T-effector cells in human cancers 81
Expression of connective tissue growth factor is a prognostic marker for patients with intrahepatic cholangiocarcinoma 81
Diffusion, outcomes and implementation of minimally invasive liver surgery: a snapshot from the I Go MILS (Italian Group of Minimally Invasive Liver Surgery) Registry 81
Laboratory test variability and Model for End-Stage Liver Disease score calculation: effect on liver allocation and proposal for adjustment 80
Pan-cancer Alterations of the MYC Oncogene and Its Proximal Network across the Cancer Genome Atlas 80
The FXR agonist obeticholic acid inhibits the cancerogenic potential of human cholangiocarcinoma 79
Forcing ATGL expression in hepatocarcinoma cells imposes glycolytic rewiring through PPAR-α/p300-mediated acetylation of p53 79
Down-staging of hepatocellular carcinoma prior to liver transplantation: the power of selection 79
Association of polygenic risk score and bacterial toxins at screening colonoscopy with colorectal cancer progression: A multicenter case-control study 79
Impact of model for end-stage liver disease (MELD) score on prognosis after hepatectomy for hepatocellular carcinoma on cirrhosis 78
The pattern of hMENA isoforms is regulated by TGF-β1 in pancreatic cancer and may predict patient outcome 78
Italian Clinical Practice Guidelines on Cholangiocarcinoma – Part I: Classification, diagnosis and staging 78
Liver resection for hepatocellular carcinoma on cirrhosis: a univariate and multivariate analysis of risk factors for intrahepatic recurrence 77
Multicohort and cross-platform validation of a prognostic Wnt signature in colorectal cancer 76
Multiple hepatocellular carcinoma: Long-term outcomes following resection beyond actual guidelines. An Italian multicentric retrospective study 76
Comparison of recurrence of hepatocellular carcinoma after resection in patients with cirrhosis to its occurrence in a surveilled cirrhotic population 75
Laparoscopic liver resection of hepatocellular carcinoma located in unfavorable segments: a propensity score-matched analysis from the I Go MILS (Italian Group of Minimally Invasive Liver Surgery) Registry 75
Liver transplantation for hepatocellular carcinoma: further considerations on selection criteria 74
Comparison between the fifth and sixth editions of the AJCC/UICC TNM staging systems for hepatocellular carcinoma: multicentric study on 393 cirrhotic resected patients 74
Key components of a hepatobiliary surgery curriculum for general surgery residents: results of the FULCRUM International Delphi consensus 73
FGFR2 fusion proteins drive oncogenic transformation of mouse liver organoids towards cholangiocarcinoma 73
Curative versus palliative treatments for recurrent hepatocellular carcinoma: a multicentric weighted comparison 72
Perspectives from Italy during the COVID-19 pandemic: nationwide survey-based focus on minimally invasive HPB surgery 70
Impact of a goal-directed fluid therapy on length of hospital stay and costs of hepatobiliarypancreatic surgery: A prospective observational study 70
Benchmarking postoperative outcomes after open liver surgery for cirrhotic patients with hepatocellular carcinoma in a national cohort 70
Adjuvant systemic chemotherapy after putative curative resection of colorectal liver and lung metastases 69
Molecular Aging of Human Liver: An Epigenetic/Transcriptomic Signature 68
Outcome of Right Hepatectomies in Patients Older Than 70 Years 68
Evolution of pancreatectomy with en bloc venous resection for pancreatic cancer in Italy. Retrospective cohort study on 425 cases in 10 pancreatic referral units 68
Current status of liver surgery for non-colorectal non-neuroendocrine liver metastases: the NON.LI.MET. Italian Society for Endoscopic Surgery and New Technologies (SICE) and Association of Italian Surgeons in Europe (ACIE) collaborative international survey 67
Aberrant Notch3 and Notch4 expression in human hepatocellular carcinoma 67
Multicentre evaluation of case volume in minimally invasive hepatectomy 67
Hepatitis C virus recurrence after liver transplantation: a 10-year evaluation 67
Six score systems to evaluate candidates with advanced cirrhosis for orthotopic liver transplant: which is the winner? 66
Liver allocation for hepatocellular carcinoma: a European Center policy in the pre-MELD era 66
Analysis of factors affecting recurrence of hepatocellular carcinoma after liver transplantation with a special focus on inflammation markers 66
Associated benign liver tumors in idiopathic granulomatous hepatitis: a case report 66
Liver and partial atrium transplantation for chronic Budd-Chiari syndrome 66
Italian Clinical Practice Guidelines on Cholangiocarcinoma - Part II: Treatment 66
Efficacy of MELD score in predicting survival after liver retransplantation 65
Robotic Liver Resections: Application of Difficulty Score Systems to an Initial Experience. Is a Specific Robotic Difficulty Score Necessary? 65
The peculiar aging of human liver: A geroscience perspective within transplant context 65
Systemic fungemia and hepatic localizations of Fusarium solani in a liver transplanted patient: An emerging fungal agent 64
A bioluminescent mouse model of proliferation to highlight early stages of pancreatic cancer: A suitable tool for preclinical studies 64
The largest western experience on salvage hepatectomy for recurrent hepatocellular carcinoma: propensity score-matched analysis on behalf of He.RC.O.Le.Study Group 64
Laparoscopic Liver Surgery: What Are the Advantages in Patients with Cirrhosis and Portal Hypertension? Systematic Review and Meta-Analysis with Personal Experience 64
Is it time to develop a robotic difficulty score system? 63
Recommendations for management of patients with neuroendocrine liver metastases 62
Down-staging of hepatocellular carcinoma before liver transplantation: should we change our clinical practice? 62
Daclizumab and alemtuzumab as induction agents in adult intestinal and multivisceral transplantation: rejection and infection rates in 40 recipients during the early postoperative period 62
Improving the outcome of liver transplantation with very old donors with updated selection and management criteria 61
Organ-saving surgery for rectal cancer after neoadjuvant chemoradiation: Analysis of failures and long-term results 60
Liver transplantation for recurrent hepatocellular carcinoma on cirrhosis after liver resection: University of Bologna experience 60
Histological recurrent hepatitis C after liver transplantation: Outcome and role of retransplantation 60
Coping strategies in intestinal transplantation 60
A room for the alpps procedure in patients with HCC 60
Hepatectomy Versus Sorafenib in Advanced Non-Metastatic Hepatocellular Carcinoma: A Real-Life Multicentric Weighted Comparison 60
Totale 8.503
Salva come PNG Salva come JPEG
Categoria #
all - tutte 113.387
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 113.387
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021135 0 0 0 0 0 0 0 0 0 0 110 25
2021/2022629 15 114 7 6 13 11 127 73 41 22 58 142
2022/2023798 75 45 8 50 46 398 9 41 64 4 35 23
2023/2024498 38 79 38 22 24 18 14 19 19 8 30 189
2024/20253.203 115 49 326 3 378 394 59 129 402 838 238 272
2025/20267.458 467 344 853 1.016 934 318 679 507 1.024 1.285 31 0
Totale 13.232